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| INTRODUC TI ON
Prospective studies published to date have found now no evidence of neurotoxicity in young children, after a single exposure to anesthetic agents. [1] [2] [3] On the other hand, recent papers discussing acute severe brain damage associated with general anesthesia, particularly in neonates and infants, are challenging our perception of safety of our current practice of pediatric anesthesia. 4, 5 In a case series, McCann et al delineated the development of postoperative encephalopathy in six infants, where periods of hypotension and/or hypocapnia may have contributed to (prolonged) periods of cerebral hypoperfusion. 6 Despite research using various methods to determine individual lower limits of blood pressure (BP) in anesthetized infants to prevent them from anesthesia associated acute brain damage, [7] [8] [9] [10] [11] [12] there is still no consensus regarding safety margins of BP in anesthetized infants. 13 Many pediatric anesthetists instinctively link cerebral hypoperfusion with low blood pressure. However, arterial blood pressure (BP) is no more than one of the factors contributing to the maintenance of cerebrovascular autoregulation and is not a surrogate for cerebral perfusion or tissue perfusion in general (see Figure 1 ).
Despite compelling evidence that BP does not reflect end-organ perfusion, it is still regarded as the most important determinant of cerebral perfusion by most (pediatric) anesthetists.
Near-infrared spectroscopy (NIRS) is a non-invasive technology that provides real-time information regarding tissue oxygenation.
A growing body of evidence emerging from pediatric cardiac anesthesia papers suggests that NIRS detected cerebral desaturation is linked to bad neurological outcome. 14, 15 When interpreted together with standard monitoring parameters, cerebral NIRS provides the anesthetist with early warning signs of impaired tissue perfusion, ventilation, and oxygenation, allowing one to draw conclusions as to the cause 16 and subsequently enabling immediate interventions to prevent the child from potentially life-threatening complications or at least to reduce their severity. 17 While it has become a standard of care in many pediatric cardiac centers and neonatology units, NIRS monitoring is not yet widely applied in children undergoing noncardiac surgical procedures. The majority of papers delineating the use of NIRS monitoring during major noncardiac pediatric surgery have been published in surgical journals. In these pediatric surgical studies, NIRS was often used as a monitoring tool to address possible safety issues of new surgical techniques, such as thoracoscopic repair of congenital diaphragmatic hernia or esophageal atresia. [18] [19] [20] The aim of this article is threefold: Firstly, we give a practical introduction to near-infrared spectroscopy (NIRS) in pediatric patients. Secondly, we present our approach to managing hemodynamics and maintaining adequate cerebral perfusion/tissue oxygenation, using regional cerebral tissue oxygenation (c-rSO 2 ) measured by NIRS as the central target parameter. Finally, we shall share with you our thoughts about the future of NIRS monitoring in pediatric anesthesia.
| A PR AC TI C AL INTRODUC TI ON TO NE AR-INFR ARED S PEC TROSCOPY (NIR S)

| The technical background of near-infrared spectroscopy (NIRS)
NIRS technology applies light wavelengths within the 650-1100 nm range, the so-called "optical window" for measuring tissue oxygenation. As opposed to ultraviolet, infrared, and visible light, near-infrared (NIR light) is not strongly absorbed by water, proteins or hemoglobin and scatters less, making it capable of providing information from the inner body after analysis of its spectrum. 21 Within the NIR spectrum, photons can penetrate tissue several centimeters and even penetrate bone, the latter being a prerequisite for transcranial NIRS monitoring. 22 NIRS monitoring provides realtime information regarding the difference between tissue oxyhemoglobin and deoxyhemoglobin, reflecting tissue oxygen uptake, and consumption. 23 The basic principle of the currently commercially available medical NIRS devices is the application of a sensor which emits 2-5 different wavelengths of light within the NIR spectrum into tissue. The The measurements reported by the current NIRS devices are expressed by the device manufacturers as either regional oxygen saturation rSO 2 or tissue oxygenation index TOI, 31 which are both expressions of the percentage of tissue oxyhemoglobin.
Unfortunately, in the scientific literature many other abbreviations can be found, such as StO 2 , ScO 2 , and SctO 2 ; actually, all of them are expressions of regional tissue oxygenation but this inconsistency in reporting creates more confusion.
| Parameters contributing to c-rSO 2
Physiological parameters known to contribute to the cerebral oxygen delivery/demand balance need to be considered as relevant when interpreting c-rSO 2 . Oxygen delivery to the brain is basically a function of cardiac output, perfusion pressure, oxygenation, and hemoglobin concentration. Oxygen demand is furthermore related to the cerebral metabolic rate (CMR) which is reduced by all currently used anesthetic drugs except ketamine, which causes a rise in CMR. 32 (Pediatric) anesthetists traditionally rely on standard monitoring parameters like blood pressure, heart rate, pulse oximetry to assess their patient's cardiocirculatory and respiratory status.
Continuous (non-invasive) measurement of cardiac output, though technically possible, 33, 34 has not yet become common practice in pediatric anesthesia. A growing body of evidence suggests that arterial blood pressure, though not a good estimate of cerebral perfusion, seems to contribute mostly to changes in c-rSO 2 . 35 Heart rate is also important, especially in neonates and young infants.
The arterial carbon dioxide tension (PaCO 2 ) also significantly contributes to cerebral blood flow with hypocarbia resulting in cerebral vasoconstriction and reduced cerebral blood flow and hypercarbia resulting in vasodilation and increased cerebral blood flow. In a pediatric study, de Waal et al could show that increasing the P a CO 2 from 32 to 40 mm Hg in anesthetized patients resulted in an increase in c-rSO 2 from 61% to 70%. 36 The arterial oxygen tension (PaO 2 ) appears to contribute to c-rSO 2 to a lesser degree than P a CO 2 37 but should be considered as well, especially during acute hypoxic events.
Anemia becomes relevant for c-rSO 2 when hemoglobin levels are too low to deliver an oxygen-carrying capacity that meets the demands of cerebral oxygen consumption. Under these conditions, transfusion of red blood cells has been shown to result in increased c-rSO 2 values. 38 It should be kept in mind that in a surgical setting, a decrease in c-rSO 2 can be due to low hemoglobin concentrations following acute blood loss even before decreases in blood pressure occur.
Other physiological parameters, such as body temperature and blood glucose level, also contribute to cerebral perfusion. If possible, any parameter measured should be kept within its age-related and/ or patient-specific physiologic range.
As opposed to the cardiorespiratory monitoring parameters, we are used to rely on, such as heart rate, blood pressure, oxygen saturation, and carbon dioxide partial pressure, a c-rSO 2 value is not a "stand-alone" parameter; it is more or less the ultimate expression of the interplay between the aforementioned contributing parameters (see Figure 1 ). The course of a NIRS reading should therefore always be interpreted in the context of the course (and the possible changes) of the factors contributing to it. In a recent editorial, Skowno et al 14 referred to NIRS as a "multidimensional monitor" enabling the interpretation of multiple variables influencing cerebral blood flow.
| NIRS monitoring in children under chronic hypoxemic conditions
A closer look at NIRS monitoring in children with cyanotic heart disease nicely illustrates the fundamental difference between NIRS and pulse oximetry. 39, 40 While the pulse oximeter shows an oxygen saturation of 85%, NIRS-derived c-rSO 2 values are around 70%, equaling the range usually seen in awake healthy children with an oxygen saturation of ±98%. This equality in c-rSO 2 values can easily be ex- between 33% and 44% for acute brain energy failure and brain metabolic dysfunction. Another animal study performed by Kurth et al 53 showed that brain tissue injury depends on both severity and duration of ischemia. As severity or duration of ischemia increase, the degree of damage increases. In piglets subjected to a c-rSO 2 of 45% from 1 to 8 hours and subsequently recovered, brain injury by histologic and behavioral examination was not evident until 2 hours c-rSO 2 45%; then, the incidence of brain injury increased 15% per hour, such that by 8 hours c-rSO 2 45%, all piglets displayed brain injury.
| Improper use of medical NIRS devices-More than just kidneys and vegetables
In neonates after Norwood stage I palliation for hypoplastic left heart syndrome (HLHS) Dent et al 54 to represent the anaerobic threshold. 55 The authors of this study specifically concluded that even c-rSO 2 values >50% are not necessarily reassuring.
Pellicer et al recommended a nonindividualized c-rSO 2 target range between 55% and 58% for extremely premature infants, 56 which was intended to avoid both cerebral hypoxia and hyperoxia.
Stolwijk et al adopted this recommendation in a case series of neonates undergoing thoracoscopic repair of long gap esophageal atresia and added an individual feature to it by trying to avoid fluctuations in c-rSO 2 of more than 20% from baseline. 57 Until now, a consensus regarding a lower limit of NIRS-derived c-rSO 2 values, serving as an intervention threshold, could not be reached.
| Limitations of cerebral NIRS monitoring
There are clinical situations in which NIRS values are difficult to in-
terpret. An almost classic scenario is connecting the NIRS monitor intraoperatively at the moment the patient's conditions begin to deteriorate (ie, low blood pressure, low SaO 2 , etc). As we do not have validated nonindividualized lower c-rSO 2 safety margins available, in these cases interpretation of NIRS values is problematic, apart from extremes; that is a c-rSO2 value of 30%, usually accompanied by a low SaO2-value is without any doubt an urgent call for action, whereas a c-rSO 2 value of 85% speaks for a sufficient cerebral oxygenation. However, without knowledge of the individual awake baseline c-rSO 2 value it is difficult, if not impossible to draw a meaningful conclusion as to a c-rSO 2 value of for example ±60%.
| NIRS and patient outcome
Cerebral NIRS monitoring has been used in pediatric cardiac anesthesia for more than two decades. While some centers integrated c-rSO 2 monitoring into their clinical protocols of perioperative hemodynamic management, others decided not to rely on NIRS monitoring. Today, there is little doubt as to the predictive value of NIRS monitoring with regard to early outcome after pediatric cardiac surgery. 15, 17 As opposed to pediatric cardiac patients, few data are available regarding NIRS monitoring and outcome after pediatric noncardiac surgery. Olbrecht et al published an observational multicenter study in 453 infants <6 months receiving anesthesia for noncardiac surgical procedures and found a 43% incidence of mild cerebral desaturation measured by NIRS, whereas the incidences of usually short periods of severe cerebral desaturation were as low as 1.55% for absolute c-rSO 2 values <50% and 0.95% for a 30% decline from baseline. 58 In In a 2011 review article, Greisen et al estimated that a trial with sufficient power to detect a 20% reduction of the incidence of brain injury in extreme premature neonates should recruit about 4000 patients. 60 A recent international phase II feasibility randomized clinical trial in 160 extremely preterm infants showed a reduction in cerebral hypoxic events due to a NIRS-guided treatment protocol 56 but failed to detect any effect on the occurrence of early biomarkers of brain injury or EEG burst rates 61 and neurodevelopmental outcome at 2 years of age. 62 In this neonatal ICU trial, only one intervention to normalize c-rSO 2 values was allowed at a time and the patient was re-assessed 30-60 minutes later. Transient anticipated changes in c-rSO 2 values due to routine interventions (ie, endotracheal tube suctioning) were not listed in the treatment protocol. A subsequent trial, aiming to recruit 1600 patients, has been designed by the same consortium to investigate the possible impact of their NIRS protocol on the incidence of death or severe brain injury at 36 weeks. 63
| NIR S-DIREC TED HEMODYNAMIC MANAG EMENT: THE BA S ELINE-BOT TOMLINE APPROACH
We fully agree with Scott and Hoffman stating that "NIRS opens a window for regional circulation monitoring that can drive organ-specific goal-directed treatments". 30 It is furthermore currently widely accepted that NIRS-derived c-rSO 2 is a reliable non-invasive surrogate parameter of the cerebral oxygen supply/demand balance.
Other parameters, among which blood pressure, heart rate, S a O 2 , and P a CO 2 , significantly contribute to cerebral perfusion, but they provide no good estimate of cerebral perfusion. Simultaneous interpretation of NIRS and contributing parameters currently provides us with the most reliable information regarding the cerebral oxygen supply/demand balance. 14, 16 As a consequence, our strategy to ensure adequate cerebral perfusion and oxygen delivery uses cerebral rSO 2 as the single target parameter, while BP, heart rate, P a CO 2 , etc are contributors serving rSO 2 .
It may appear somewhat counterintuitive to recommend the use of a parameter (c-rSO 2 ) which comes short of a clearly defined normal range as the central target parameter of hemodynamic management. Worse still, there are also no generally accepted intervention targets for low c-rSO 2 values. Finally, c-rSO 2 values are device specific. [46] [47] [48] However, we do not regard these points as a shortcoming, as long as it is possible to obtain an individual c-rSO 2 baseline value, measured under awake conditions. Awake is the magic word here:
We assume that as long as the child is awake and responsive, cerebral perfusion and oxygenation are both sufficient.
This clearly puts a strong case for handling an individualized c-rSO 2 target for children under anesthesia conditions. The key to our concept is to keep the child's cerebral oxygenation within a range of c-rSO 2 values which we know to be safe, which means higher than awake baseline, instead of allowing the c-rSO 2 to decline until we begin to feel uneasy with the child's condition. Basically, we are aiming at maintenance of an optimal condition rather than treatment of potentially harmful cerebral desaturation. We call this strategy our Baseline-Bottomline approach. Contrary to the treatment guideline developed by the SafeBooS-C research consortium, 56 we take into account any change of the c-rSO 2 under anesthesia conditions with a focus on immediate restoration of normal values.
Our clinical approach to NIRS-directed hemodynamic management is quite straight forward: The child is attached to the NIRS monitor prior to induction of anesthesia to obtain an awake baseline value. This baseline value is considered to reflect adequate cerebral oxygenation. If possible, we measure an awake baseline blood pressure and baseline values of heart rate and pulse oximetry.
Unfortunately, it is not always possible to obtain an awake baseline blood pressure. 12 Contrary to this awake blood pressure issue, we cannot remember a single patient where it was not possible to obtain an awake baseline c-rSO 2 value. Our experience is that c-rSO 2 val- In our institution, we currently use cerebral NIRS monitoring in noncardiac surgical neonates and other patients assumed to be at high risk of impaired cerebral perfusion during the course of an anesthetic, including the period before surgical incision and the emergence period. While NIRS monitoring in (preterm) neonates has become a standard of care in our institution, we do not yet have a clinical guideline as to the indication for NIRS monitoring in older children. In our hospital, the decision to restrict the use of NIRS monitoring to patients assumed to be at an increased risk of anesthesia associated hypoxic-ischemic neurologic injury is mainly economically driven.
In terms of evidence-based medicine, our Baseline-Bottomline approach is no more than a level III recommendation. It may also 
| THE FUTURE: MULTIS ITE NIR S MONITORING AND COMP OS ITE PAR AME TER S
Simultaneous application of NIRS probes on the forehead and other regions of the body, usually referred to as multisite NIRS monitoring is becoming increasingly popular, at least in research settings.
Renal rSO 2 values simultaneously recorded with c-rSO 2 may provide relevant additional information regarding renal function. 30 Muscle rSO 2 values also simultaneously recorded with c-rSO 2 have been used as early markers of centralization of the circulation in premature neonates. 64 
| CON CLUS ION
NIRS monitoring can help maintain sufficient tissue perfusion/oxygenation in anesthetized children. Our approach defining baseline awake c-rSO 2 values as the lower limit is fundamentally different from previously reported treatment algorithms defining lower limits of c-rSO 2 values by either percentage reductions compared to baseline or absolute values assumed to be associated with cerebral hypoxemia. Cerebral NIRS monitoring, interpreted together with its continuously available contributing parameters (BP, P a CO 2 , HR, and SaO 2 ), may help avoid potentially harmful episodes of cerebral desaturation in anesthetized pediatric patients.
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